Dong and co-workers showed that shRNA-mediated knockdown of MMP2 in HT-29 and SW480 colon tumor cells clearly reduced their invasion capabilities in Boyden-chamber assays [52]. This evidence concerns the gene MMP2 and colonic neoplasm.